(Alliance News) - AstraZeneca PLC on Tuesday took the rare step of addressing a sharp fall in the company's share price. Shares in the Cambridge-based pharmaceuticals company slumped 8.2% to 10,138.10 ...

AstraZeneca’s stock price dropped by 8.4% during Tuesday’s trading in London after a report fueled fears of a potentially ...

Chinese authorities detained AstraZeneca employees amid a probe into data privacy breaches and unlicensed drug sales, stock ...

Vestas Wind Systems A/S posted the largest decline among large stocks during the session, plunging 12.2%, followed by Ambu A/S Series B shares, which declined 8.7%. Shares of AstraZeneca PLC declined ...

Weighing on London, AstraZeneca fell 8.2%, losing its top spot as the most valuable company on the FTSE 100 to oil major Shell in the process. The Cambridge-based pharmaceuticals firm fell back ...

AstraZeneca shares recorded their biggest one-day drop since March 2020 on Tuesday following a report that dozens of senior ...

And the leaders, both of whom previously served at rare disease ... (In 2020, Alexion was bought by AstraZeneca for $39 ...

The pharma giant confirmed that Wang Lei, the executive vice president who oversaw AstraZeneca’s rapid expansion in China, is ...

An investigation involving the drugmaker’s China president is the latest industry crackdown to trigger uncertainty about ...

Leon Wang, EVP international and AstraZeneca China President, is cooperating with an ongoing investigation by Chinese ...

AstraZeneca said on Wednesday the company's China President Leon Wang is currently under investigation and is cooperating with Chinese authorities.

In a frothy market starved for value, these three dividend stocks combine reasonable valuations with the proven ability to ...